With 37 new spin-offs, ETH Zurich continues its long-term upward trend in the launch of new companies from its research.

Das Startup naoo mit seiner schnell wachsenden Social App hat mit GEM Global Yield eine Finanzierungsvereinbarung über 25 Millionen Euro Eigenkapital abgeschlossen. Das zusätzliche Kapital wird naoo ...

Helix Robotics is developing the first commercial soft robot manipulator, addressing the need for human-friendly and reliable robotics. By combining the safety of soft robotics with industrial ...

Swiss startup Oxyle announced a $16m funding round to scale its breakthrough solution to destroy, not just relocate, PFAS from wastewater. This builds on its $3M pre-seed round in 2022, growing ...

Marktkonsolidierung in der Camper-Branche: Das Burgdorfer KMU Yellowcamper, ein führendes Unternehmen für den individuellen ...

BioVersys AG, a multi-asset, clinical stage biopharmaceutical company focusing on research and development of novel antibacterial products for serious life-threatening infections ...

Yokoy, the leading spend management platform, has been acquired by TravelPerk, a business travel platform based in Barcelona. In parallel, TravelPerk announced the closing of a financing round in ...

Startups supported by Venture Kick have made remarkable achievements, with 66 Venture Kick alumni recognized among the TOP 100 Swiss Startups 2024. And despite a difficult fundraising environment, the ...

Recent startup challenges are offering new platforms for startups to showcase and advance their solutions. Elythor and Prometheus are competing for a €100,000 grand prize in the HelloTomorrow ...

Over the past two years, Voltiris has reached significant milestones, including 12 commercial projects with renowned growers in Europe, partnerships with leading energy utilities such as Elektra ...

Nach knapp zwei Jahren Entwicklung und Pilotierung hat das Startup RY3T nun mit der ersten Serie seiner innovativen Heizsysteme den Markteintritt gestartet. Das System nutzt die anfallende Abwärme der ...

AB2 Bio has entered into an option and licensing agreement with Nippon Shinyaku Co. Ltd., a leading Japanese pharmaceutical company with extensive experience in marketing rare disease therapeutics in ...